Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
about
Schistosomiasis vaccinesPreclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemicHelminth parasite proteomics: from experimental models to human infectionsImmunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigensSchistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantelPredicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobiumHost determinants of reinfection with schistosomes in humans: a systematic review and meta-analysisNo apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission areaInduction of protective immune responses against schistosomiasis using functionally active cysteine peptidasesRegulatory and activated T cells in human Schistosoma haematobium infections.Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray.Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.Immunology of human schistosomiasis.Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells.Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni.Efficacy and safety of arachidonic acid for treatment of school-age children in Schistosoma mansoni high-endemicity regionsProportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobiumSchistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.Innate immunostimulatory properties of allergens and their relevance to food allergy.Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection.Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infectionParasite glycans and antibody-mediated immune responses in Schistosoma infection.Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.Immuno-evasive tactics by schistosomes identify an effective allergy preventative.Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population.Paediatric schistosomiasis: What we know and what we need to know.Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.Schistosomiasis therapeutics: whats in the pipeline?Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.The Interdependence between Schistosome Transmission and Protective Immunity
P2860
Q24598949-A2398333-0D9E-4E4C-8931-F1C2216975FBQ24635389-BFFB8975-DC89-47C6-9D0D-84013CD8A7A9Q26863301-5E8552FF-5B39-4627-B689-5F05D703C9F7Q27305172-88348956-0312-4AD4-B78E-5A32FE103564Q28478162-62A0BD30-0856-4BE6-83B9-EBEFDEF70231Q28541406-AEA9D7D9-C4E2-4E50-9658-516EE34C4AF7Q28542932-44B38781-D6C9-4F13-B39E-B8AA7C6CE16AQ28543650-B1381C48-FF5B-47B6-8FC9-B4395001F0B4Q33611746-BBC05712-F936-4773-838F-C62C11C53098Q33828497-F8C2D2F8-616F-423E-9025-EADB757DD042Q34500892-B8C19BD0-8AF0-40DD-9C11-CACE2C0C842BQ34626114-3CBAB038-428E-4559-BF42-5249A2620092Q34626126-85692623-2B47-4E3D-A41C-7366F41F1104Q34654313-FC3E19F2-429D-4FB0-B42F-3CE69B102520Q34782228-A35E98EC-ADAE-4C10-BD98-507BED7092DEQ35088439-5C6CE8EE-68A6-4A79-AA19-C014CF1F429BQ35191872-DCE2B16C-83DE-414E-AC01-564053D71251Q35230008-40DA1527-24FE-4D3C-BA2C-52039D6F0282Q35272747-C2E651DB-318D-4444-AC0D-36A60CB781F5Q36057144-4152F21E-2C20-4CC7-BE38-6171B19100B0Q36158825-796BA9E9-2F02-45D0-86C3-C46D9D285FACQ36283976-0A9E7530-23E5-4DA0-A8E3-45A0CA077186Q36942712-6DE4E5E3-F08A-48F7-8B73-85386ED79127Q37226715-852A3A16-52E2-4340-862B-2FDF3C296D1BQ37994231-906E9EDE-BCF0-444C-918F-7087CB9C777CQ40079529-13F257AB-BF79-4A05-A9C1-D0D62A6ED484Q41373939-026B9C2A-7999-450C-BC97-B43868BD4A5DQ46430580-95055E99-D8F1-4E8A-864A-FF81BF15E24BQ50114695-ED156608-B0DB-40A7-8920-004578275B90Q50532009-69E06492-D352-446F-AAF4-6F0C2AB6B6ADQ50966400-A551CF61-642D-46B3-A363-1AA0F67D799DQ53697118-D622AD57-5836-445C-B8E8-2B2D7E04404DQ57152572-5A4C8BCD-508C-4824-9F04-1E83F8B3AD03
P2860
Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@ast
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@en
type
label
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@ast
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@en
prefLabel
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@ast
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@en
P2093
P2860
P356
P1476
Increases in levels of schisto ...... tion with Schistosoma mansoni.
@en
P2093
Carla L Black
Daniel G Colley
Diana M S Karanja
Erick M O Muok
Jennifer M Carter
Pauline N M Mwinzi
W Evan Secor
P2860
P304
P356
10.1086/653828
P407
P5008
P577
2010-08-01T00:00:00Z